Effects of chromium picolinate supplementation in type 2 diabetic patients



Document title: Effects of chromium picolinate supplementation in type 2 diabetic patients
Journal: Acta scientiarum. Health science
Database: PERIÓDICA
System number: 000393271
ISSN: 1679-9291
Authors: 1
2
1
1
1
1
Institutions: 1Universidade Estadual de Maringa, Departamento de Analises Clinicas e Biomedicina, Maringa, Parana. Brasil
2Universidade Estadual de Maringa, Departamento de Farmacologia e Terapeutica, Maringa, Parana. Brasil
Year:
Season: Jul-Dic
Volumen: 36
Number: 2
Pages: 160-164
Country: Brasil
Language: Inglés
Document type: Artículo
Approach: Experimental, caso clínico
English abstract The effects of chromium picolinate in Type 2 diabetic patients are investigated. Seventeen Type 2 diabetic patients were randomly divided into two groups. The experimental group received fiber- rich hypocaloric diet and chromium picolinate whereas the control group received fiber-rich hypocaloric diet and placebo. The chromium picolinate was offered twice a day at the dose of 100 μg. Anthropometric data such as blood pressure, fasting glycemia and glycated hemoglobin (HbA1c) were measured and these parameters were evaluated again after 90 days. No difference was reported in rates of body weight, waist, hip, body mass index, blood pressure and fasting glycemia (Control vs. Experimental groups) after treatment. However, a decrease (p = 0.0405) of HbA1c occurred in the experimental group when the pre- and post-treatment rates were compared. HbA1c data showed that chromium picolinate improved the glycemic control in Type 2 diabetes
Portuguese abstract Neste estudo investigamos os efeitos do picolinato de cromo em pacientes portadores de Diabetes mellitus tipo 2. Para alcançar este objetivo 17 pacientes foram aleatoriamente divididos em 2 grupos. O grupo Experimental recebeu dieta hipocalórica rica em fibras e picolinato de cromo enquanto o grupo Controle recebeu dieta hipocalórica rica em fibras e placebo. Picolinato de cromo foi oferecido na dose de 100 μg, 2 vezes ao dia. Avaliamos os dados antropométricos, pressão arterial, glicemia de jejum e hemoglobina glicada A1c (HbA1c), sendo estes parâmetros reavaliados após 90 dias. Os resultados de peso, cintura, quadril, índice de massa corpórea, pressão arterial e glicemia de jejum, antes e após o tratamento não foram diferentes (Controle vs. Experimental). Contudo, houve redução (p = 0,0405) da HbA1c no grupo Experimental, ao compararmos os valores antes e após o tratamento. Portanto, a partir dos dados de HbA1c foi possível evidenciar que o picolinato de cromo melhora o controle glicêmico no Diabetes mellitus tipo 2
Disciplines: Medicina
Keyword: Metabolismo y nutrición,
Terapéutica y rehabilitación,
Diabetes,
Hemoglobina glicada,
Control glicémico,
Fibra,
Cromo,
Suplementación
Keyword: Medicine,
Geriatrics,
Metabolism and nutrition,
Nephrology,
Therapeutics and rehabilitation,
Diabetes,
Glycated hemoglobin,
Glycemic control,
Fiber,
Chromium,
Supplementation
Full text: Texto completo (Ver PDF)